Trials / Completed
CompletedNCT03261128
Tool for the Detection of Oncogeriatric Fragility in Patients Aged ≥75 Years Undergoing Oncological Treatment.(D-FOG)
Tool for the Detection of Oncogeriatric Fragility in Patients Aged ≥75 Years Undergoing Oncological Treatment. Feasibility and Acceptability Study.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Poitiers University Hospital · Academic / Other
- Sex
- All
- Age
- 75 Years
- Healthy volunteers
- Not accepted
Summary
Many cancers are diagnosed after 75 years. Treatment in chemotherapy begins without evidence of geriatric risk factors. A new tool for screening for geriatric fragilities is used, a self-administered questionnaire carried out by the patient before each chemotherapy cure. The objective is to secure the quality of patient care and to detect the appearance and / or aggravation of geriatric fragilities.
Detailed description
Evaluation of the feasibility of a new geriatric fragility screening tool (D-FOG) in patients aged ≥ 75 years during oncological treatment: * Number of D-FOGs filled in: comparison with the number of patients included in the study and the number of visits of each patient. * Regularity of the D-FOG self-questionnaire by the patient: comparison with the number of visits of the patient for a chemotherapy cure (HDJ or HDS). * Number of criteria entered by D-FOG: comparison with the total number of criteria to be filled in * Criterion analysis of D-FOG
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Self-questionnaire | Filling of a self-questionnaire before each chemotherapy cure |
Timeline
- Start date
- 2017-11-21
- Primary completion
- 2018-09-11
- Completion
- 2018-12-05
- First posted
- 2017-08-24
- Last updated
- 2019-01-29
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03261128. Inclusion in this directory is not an endorsement.